Foundation Program Sites

Lung Health: Lung Cancer Screening and Tobacco Cessation

Join our conversation

In person

If you are unable to join with the below options, there will be a physical space reserved in the Foundation for Health Care Quality’s Seattle office to participate in the virtual meeting at the below address:


Industrious 400U @ Rainier Square
400 University Street
Floor 3
Seattle, WA 98101

Directions to FHCQ Office

Online

Meeting ID: 231 953 484 000 36
Passcode: 74Qn7SJ3

Background

Tobacco use is the third leading risk factor for death and disability in Washington state, with lung cancer being a major cause of mortality.[i] Early detection through lung cancer screening results in significantly improved survival at 20 years,[ii] but only 14.1% of high-risk Washingtonians are adequately screened for lung cancer, placing the state 26th nationwide in screening rates for high-risk individuals.[iii] The chances of surviving lung cancer greatly increases by stage of diagnosis; while over 50% of diagnoses occur once the cancer has spread, those diagnosed before it has spread have a significantly higher chance of survival.[iv] Some folks are less likely to receive adequate lung cancer screening including those who identify as Black or Hispanic.[v] Additionally, smoking-related health care costs in Washington amount to $2.8 billion annually, with $2.2 billion lost in productivity each year.[vi] While e-cigarette use is not currently a qualifying factor for lung cancer screening, many individuals use both and current e-cigarette users are 21% less likely to have undergone lung cancer screening (LCS).[vii]

 

Next Meeting Time Materials
Jan 7th, 2026 3:00-4:30pm Please see below

Meeting Materials

Date Materials
January 7th January Agenda
Draft Charter
Draft Workplan
February 4th February Agenda
January Minutes
Draft Workplan / Evidence Table
March 4th March Agenda
February Minutes
Evidence Table / Materials
April 1st April Agenda
March Minutes
Evidence Table / Materials
May 6th May Agenda
April Minutes
Evidence Table / Materials
June 3rd June Agenda
May Minutes
Evidence Table / Materials
July 1st July Agenda
June Minutes
Evidence Table / Materials
August 5th August Agenda
July Minutes
Evidence Table / Materials
September 2nd September Agenda
August Minutes
Evidence Table / Materials
October 7th October Agenda
September Minutes
Evidence Table / Materials
November 4th November Agenda
October Minutes
Evidence Table / Materials
December 2nd December Agenda
November Minutes
Evidence Table / Materials
 

Workgroup Members

Name Title Organization
Joelle Fathi, DNP, RN, ARNP, ANP-BC, CTTS, FAANP, FAAN (chair) Chief Healthcare Delivery Officer GO2 for Lung Cancer
Kristin Bohreer, RN, BSN Clinical Program Manager Early Lung Cancer Programs Virginia Mason Medical Center
Ty Jones, MD, CPPS, CHPW, CAQSM Medical Director, Patient Safety and Healthcare Quality Leader Regence
Susanne Quistgaard, MD Medical Director, Provider Customer Engagement Premera
Norilyn De La Pena Project/Program Manager II Public Health Seattle King County
Brandon Omernik, MS, CTTS Certified Tobacco Treatment Specialist Fred Hutch Cancer Center
Drew Oliveira, MD, MHA Medical Director Washington Health Alliance
Matty Triplette, MD, MPH Medical Director | Lung Cancer Screening & Living Tobacco Free Services Fred Hutch Cancer Center
Jessica Beach, MPH Health Equity Director Molina
     
     
     
     
     
     

[i] Institute for Metrics and Evaluation (n.d.). United States of America – Washington. Retrieved August 22, 2024, from https://www.healthdata.org/research-analysis/health-by-location/profiles/united-states-washington

[ii] Henschke, C. I. et al. (2023). A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Radiology, 309(2), e231988. https://doi.org/10.1148/radiol.231988

[iii] American Lung Association (n.d.). Washington. State of Lung Cancer. Retrieved August 22, 2024, from https://www.lung.org/research/state-of-lung-cancer/states/washington  

[iv] National Cancer Institute. (n.d.). Cancer stat facts: Lung and bronchus cancer. SEER. Retrieved August 29, 2024, from https://seer.cancer.gov/statfacts/html/lungb.html  

[v] Silvestri GA, Goldman L, Tanner NT, Burleson J, Gould M, Kazerooni EA, Mazzone PJ, Rivera MP, Doria-Rose VP, Rosenthal LS, Simanowith M, Smith RA, Fedewa S. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging. Chest. 2023 Jul;164(1):241-251. doi: 10.1016/j.chest.2023.02.003. Epub 2023 Feb 10. PMID: 36773935; PMCID: PMC10331628.  

[vi] Washington State Department of Health. (n.d.). Quick facts about tobacco use in Washington State. Retrieved August 22, 2024, from https://doh.wa.gov/data-statistical-reports/health-behaviors/tobacco  

[vii] Wang Q, Jiang C, Hsu ML, et al. E-Cigarette Use and Lung Cancer Screening Uptake. JAMA Netw Open. 2024;7(7):e2419648. doi:10.1001/jamanetworkopen.2024.19648